NCT01255826

Brief Summary

The purpose of this study is to evaluate sustained lung inflation followed by early nCPAP as delivery room ventilatory management for preterm neonates at risk of respiratory distress syndrome in reducing their need for mechanical ventilation and ameliorating lung injury without inducing adverse effects compared with intermittent bag and mask ventilation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Jan 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 7, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 8, 2010

Completed
1.1 years until next milestone

Study Start

First participant enrolled

January 1, 2012

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

August 31, 2017

Status Verified

August 1, 2017

Enrollment Period

1.9 years

First QC Date

December 7, 2010

Last Update Submit

August 30, 2017

Conditions

Keywords

PretermNeonatesDelivery roomResuscitationVentilationNeopuffCPAP

Outcome Measures

Primary Outcomes (2)

  • Proportionate of neonates in each group who will need endotracheal intubation after failure of positive pressure ventilation through face mask in the delivery room.

    2 minutes

  • Need for mechanical ventilation for neonates on nCPAP

    28 days

Secondary Outcomes (10)

  • Occurrence and duration of oxygen therapy.

    28 days

  • Bronchopulmonary dysplasia (BPD): defined as oxygen requirements more than 28 days.

    28 days

  • Pulmonary air leaks

    28 days

  • Patent ductus arteriosus (PDA).

    7 days

  • Necrotizing enterocolitis (NEC).

    28 days

  • +5 more secondary outcomes

Study Arms (2)

Sustained lung inflation followed by CPAP

ACTIVE COMPARATOR

Sustained pressure-controlled inflation using a neonatal mask and a T-piece ventilator (NeoPuff Infant Resuscitator; Fisher \& Paykel, Auckland, New Zealand). This will be followed by early CPAP.

Procedure: Resuscitation of preterm neonates by sustained lung inflation through T piece device followed by CPAP

Conventional self inflating bag and mask ventilation

ACTIVE COMPARATOR

Intermittent bag and mask ventilation using a self-inflating bag with an oxygen reservoir.

Procedure: Resuscitation of preterm neonates by intermittent bag and mask ventilation using self inflating bag.

Interventions

After oropharyngeal and nasal suctioning, if there are no signs of spontaneous breathing or breathing is insufficient and/or heart rate is below 100 bpm, the following approach will be followed:Pressure-controlled (20 cm H2O) inflation will be sustained for 15 secs, using a neonatal mask and a T-piece ventilator (NeoPuff Infant Resuscitator; Fisher \& Paykel).To avoid pressure leakage, we will use a neonatal mask of appropriate size which adequately cover both the mouth and nostrils of infants. This pressure controlled inflation will be followed by CPAP at 5 Cm H2O.This procedure will be repeated a second time with a pressure of 25 cm H2O for 15 secs if breathing remained insufficient and/or the heart rate is \< 100 bpm and/or the infant is cyanotic. To be followed by CPAP at 6 Cm H2O.A third puff with a pressure of 30 cm H2O for 15 secs will be used after few seconds if inadequate heart rate and respiration was not reached. This will be followed by CPAP at 7 Cm H2O.

Sustained lung inflation followed by CPAP

After oropharyngeal and nasal suctioning, if there is no signs of spontaneous breathing or breathing is insufficient and/or heart rate is below 100 bpm, intermittent mask and bag ventilation will be administrated at a rate 40-60 per minute using a self-inflating bag and mask with an oxygen reservoir.

Conventional self inflating bag and mask ventilation

Eligibility Criteria

Age27 Weeks - 33 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Preterm infants (gestational age \< 34 weeks)

You may not qualify if:

  • \. Neonates with major congenital anomalies (congenital heart disease, neural tube defect, trisomy, etc.).
  • Meconium aspiration syndrome, congenital diaphragmatic hernia and anterior abdominal wall defect.
  • Maternal chorioamnionitis. 4.Neonates with gestational age \< 26 weeks and /or birth weight less than 750 grams.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gynecology and Obstetrics hospital, Ain-Shams University

Cairo, Egypt

Location

MeSH Terms

Conditions

Respiratory Distress Syndrome, NewbornPremature BirthRespiratory Aspiration

Condition Hierarchy (Ancestors)

Respiratory Distress SyndromeLung DiseasesRespiratory Tract DiseasesRespiration DisordersInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Mohamed Sami El Shimi, MD

    Ain Shams University

    PRINCIPAL INVESTIGATOR
  • Hesham Abdel Samie Awad, MD

    Ain Shams University

    PRINCIPAL INVESTIGATOR
  • Tarek Mohey El Gammacy, MD

    Ain Shams University

    PRINCIPAL INVESTIGATOR
  • Ola Galal Badr El Deen, MD

    Ain Shams University

    PRINCIPAL INVESTIGATOR
  • Dina Mohamed Mohamed Shinkar, MSc

    Ain Shams University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

December 7, 2010

First Posted

December 8, 2010

Study Start

January 1, 2012

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

August 31, 2017

Record last verified: 2017-08

Locations